Addiction, substance abuse, and crime constitute one of the most deeply entangled relationships in criminological and public health research — so thoroughly intertwined that disentangling causation from correlation, separating substance use’s independent contribution to crime from the social structural conditions that produce both, and identifying the specific mechanisms through which psychoactive substances shape criminal behavior requires the kind of methodological rigor that only the most careful research designs can achieve. The relationship is real, consequential, and multidimensional: substances contribute to crime through the direct pharmacological effects of intoxication, through the economic imperatives of maintaining expensive addictions through property crime, through the violence embedded in illegal drug markets, and through the social network exposure to criminal associates and criminal norms that heavy drug and alcohol use environments provide. Yet none of these mechanisms is as simple as the rhetoric of the war on drugs has historically claimed, and none supports the criminalization approach that American drug policy has pursued for half a century without producing the crime reduction that criminalization promised.
Psychology and Criminology approaches substance use and crime through the dual lenses of psychological science — which has substantially advanced understanding of addiction as a brain disorder, of the specific cognitive and affective mechanisms through which substances impair the judgment and self-regulation that crime avoidance requires, and of the treatments that reduce both substance use and criminal behavior — and criminological sociology — which has documented how drug markets are organized, how drug policy shapes crime rates, and how the criminalization of drug use has produced the mass incarceration that has transformed American social structure without achieving its stated public safety goals.
Introduction
The relationship between substance use and crime operates through at least three analytically distinct pathways that the research literature identifies. The psychopharmacological pathway links the direct effects of specific substances on brain function and behavior — the disinhibition of alcohol, the paranoia of stimulant psychosis, the desperation of opiate withdrawal — to specific crime types through the specific behavioral impairments those effects produce. The economic-compulsive pathway links the financial costs of maintaining serious addictions — particularly to heroin, cocaine, methamphetamine, and prescription opioids — to property crime motivated by the economic imperative of funding substance use that legitimate income cannot support. And the systemic pathway links the organizational properties of illegal drug markets — their reliance on violence for conflict resolution in the absence of legal contract enforcement, their territorial competition, and their routine exposure to violence as an occupational hazard — to violent crime that is structurally produced by prohibition rather than by the pharmacological properties of controlled substances.
Each of these pathways has different implications for criminal justice and public health policy. If the primary mechanism is psychopharmacological — the direct effect of substance intoxication on behavior — then the most effective intervention is treatment that reduces heavy intoxication rather than the incarceration of people who are intoxicated. If the primary mechanism is economic-compulsive — property crime to fund addiction — then the most effective intervention is treatment that addresses the addiction rather than incarceration that interrupts the theft without addressing the craving that drives it. If the primary mechanism is systemic — violence embedded in illegal drug market organization — then the most effective intervention is the drug policy reform that reduces market violence by reducing the prohibition environment within which it operates rather than the enforcement intensification that compresses markets without eliminating violence.
Research by Paul Goldstein, whose tripartite framework most clearly articulated these three pathways, found that different drug-crime combinations map onto different pathways: alcohol contributes primarily through the psychopharmacological pathway; heroin and cocaine contribute substantially through the economic-compulsive pathway for dependent users who cannot fund their addiction through legitimate means; and crack cocaine in the 1980s contributed substantially through the systemic pathway as the competitive dynamics of a new and rapidly expanding market produced the violence that characterized the crack epidemic. Understanding which pathway is operative for which drug-crime combination is essential for designing drug policies that actually reduce crime rather than simply criminalizing drug users.
The Neuroscience of Addiction and Its Criminological Implications
Addiction as a Brain Disorder
The neuroscientific account of addiction — which the National Institute on Drug Abuse (NIDA) and the American Society of Addiction Medicine (ASAM) have endorsed as the consensus scientific view — proposes that addiction involves changes in the brain’s reward, motivation, memory, and control circuits that produce the compulsive drug-seeking behavior that persists despite adverse consequences. The repeated activation of the dopaminergic reward circuitry by addictive substances produces neuroadaptations — including reduced dopamine receptor density, reduced natural reward responsivity, and sensitized drug cue reactivity — that together produce the craving, compulsive use, and impaired control that characterize addiction as a clinical condition.
These neuroadaptations have direct criminological implications. Reduced responsivity to natural rewards — including the social rewards of legitimate relationships, employment, and community participation — reduces the motivational pull of the prosocial alternatives to criminal involvement that desistance research identifies as primary turning points. Sensitized cue reactivity — the automatic activation of powerful drug craving by stimuli associated with past drug use — impairs the deliberate self-regulation that avoiding criminal behavior in high-risk environments requires. And the prefrontal cortical hypofunction associated with chronic heavy substance use directly impairs the executive control functions — impulse inhibition, future orientation, consequence evaluation — that self-control theory identifies as the primary individual-level protector against criminal behavior.
Research documenting that these neuroadaptations are at least partially reversible with sustained abstinence has established the neurobiological rationale for treatment as an effective crime prevention intervention: if the brain changes that produce compulsive drug-seeking also impair the cognitive functions that support law-abiding behavior, then treatment that achieves sustained abstinence should produce both substance use improvement and crime reduction through a common neurobiological pathway. The evidence from treatment research is broadly consistent with this prediction.
Alcohol and Violence: The Disinhibition Mechanism
Alcohol is the substance most consistently and most strongly associated with violent crime in both epidemiological and experimental research. Research using victim survey data has found that alcohol is involved in approximately 40–50% of all violent crimes in the United States, including approximately 37% of sexual assaults and 15% of robberies. Research exploiting natural experiments in alcohol availability — studying violence rates in areas before and after changes in bar closing hours, alcohol outlet density, and minimum drinking age — has found consistent evidence of causal effects of alcohol availability on violence rates, establishing that the alcohol-violence association is not entirely attributable to the selection of violence-prone individuals into heavy drinking environments.
The specific mechanisms through which alcohol produces violence have been studied extensively in experimental settings. Research by Leonard and colleagues documented that alcohol impairs the cognitive appraisal processes that distinguish accidental from intentional provocations, increasing the probability that ambiguous cues are interpreted as hostile and that aggressive responses are selected. Research on alcohol-related disinhibition documented that alcohol specifically impairs the prefrontal inhibitory control systems that modulate aggressive impulses while leaving the limbic systems that generate those impulses relatively intact — producing a specific neurobiological disinhibition of aggression that explains why alcohol intoxication is consistently associated with reactive rather than premeditated violence.
Table 1. Substance Use-Crime Pathways by Drug Type
| Substance | Primary Crime Pathway | Specific Crime Association | Evidence for Causal Effect | Policy Implication |
|---|---|---|---|---|
| Alcohol | Psychopharmacological (disinhibition) | Violent crime; DUI; domestic violence | Strong — experimental + natural experiments | Alcohol outlet regulation; DUI enforcement; brief interventions |
| Heroin/opioids | Economic-compulsive (funding addiction) | Property crime; robbery; fraud | Moderate — treatment studies | Medication-assisted treatment; harm reduction |
| Crack/powder cocaine | Psychopharmacological + systemic | Violence during use; drug market violence | Moderate — market studies | Sentencing reform; diversion; treatment |
| Methamphetamine | Psychopharmacological (psychosis, paranoia) | Violent crime; property crime | Moderate — clinical studies | Treatment; brief interventions; reentry support |
| Marijuana | Weak — primarily systemic (market) | Drug market violence in prohibition context | Weak — experimental evidence limited | Decriminalization/legalization reducing market violence |
| Prescription opioids | Economic-compulsive (when transitioning to illicit use) | Property crime; prescription fraud | Moderate — regional studies | Prescribing reform; MAT access; PDMP |
Stimulants, Psychosis, and Criminal Behavior
Methamphetamine and Violence
Methamphetamine — a synthetic stimulant that produces intense euphoria, hyperarousal, and, with heavy use, paranoid psychosis — has been associated with elevated violent crime rates in the communities where its use has concentrated, through a combination of the psychopharmacological pathway’s direct disinhibition effects and the paranoia-driven aggression that stimulant psychosis produces. Research on methamphetamine-associated psychosis — which affects an estimated 10–15% of regular users and is clinically indistinguishable from schizophrenia during acute episodes — has documented the specific role of persecutory delusions and threatening hallucinations in driving the violent behavior that methamphetamine-using individuals exhibit during psychotic episodes.
Research by Cartier, Farabee, and Prendergast on the crime rates of methamphetamine users in California documented substantially elevated violent crime rates relative to other drug-using comparison groups, with the elevated violence concentrated in periods of active heavy use rather than distributed across the drug-using career. This concentration of violence in periods of heavy use — rather than its elevation throughout the drug-using career — supports the psychopharmacological rather than the selection account of methamphetamine violence: it is the drug’s direct effects during heavy use periods, not the pre-existing characteristics of methamphetamine users, that primarily explains the elevated violence risk.
Research on criminal methamphetamine users in treatment found that participation in contingency management programs — behavioral approaches that use systematic voucher incentives to reinforce negative drug test results — produced substantial reductions in both methamphetamine use and criminal behavior during the treatment period, establishing that treatment approaches effective for methamphetamine can produce crime reduction alongside substance use reduction. The Matrix Model, a structured outpatient behavioral treatment for stimulant use disorders, is among the approaches with the strongest evidence base for methamphetamine-using criminal justice populations.
Drug Markets, Prohibition, and Systemic Violence
The Organization of Illegal Drug Markets
The violence associated with illegal drug markets — the shootings, assaults, and homicides that drug market competition and conflict produce — is not a pharmacological consequence of the drugs traded but an organizational consequence of their prohibition. In legal markets, disputes about contracts, territory, and product quality are resolved through legal mechanisms — courts, arbitration, regulatory agencies. In illegal markets, the same disputes are resolved through the only mechanisms available: violence, the threat of violence, and the reputational deterrence that demonstrated willingness to use violence produces.
Research by Alfred Blumstein and others on the relationship between the crack cocaine epidemic and the homicide surge of the late 1980s documented that the specific dynamics of crack market expansion — the recruitment of young men with weapons to staff rapidly growing distribution networks, the territorial competition among expanding market participants, and the low barriers to entry that produced market instability — produced violence through market organizational dynamics rather than through crack’s pharmacological properties. Research documenting that the homicide decline of the 1990s tracked the maturation of crack markets — as territorial competition stabilized, as younger participants aged out and were replaced by more stable workers, and as the worst violence-generating market dynamics subsided — established the market organizational account of drug market violence against the purely pharmacological account.
Drug Policy Reform and Crime
Research on the crime consequences of marijuana decriminalization and legalization across multiple American states has found consistent evidence of either null or positive crime effects — decriminalization has not increased crime, and some research finds reductions in drug market-related violent crime in states following recreational legalization. Research by Morris and colleagues on crime rates in states adjacent to Colorado following its 2012 legalization found no evidence of crime spillover effects, while research on within-state crime rates found modest reductions in some crime categories consistent with the drug market violence reduction that legalization of a previously illegal market would predict.
The crime consequences of the opioid epidemic — the surge in prescription opioid misuse beginning in the late 1990s, transitioning to heroin and illicit fentanyl use as prescription controls tightened — represent a distinct drug-crime dynamic that illustrates the economic-compulsive pathway at population scale. Research by Rosenfeld and colleagues found consistent associations between opioid use rates and property crime rates across states and over time, establishing the economic dimension of the opioid-crime relationship through the specific mechanism of property crime to fund addiction that the economic-compulsive pathway specifies.
Adolescent Substance Use and Delinquency
Research on adolescent substance use and delinquency has documented a robust association that requires careful causal interpretation: alcohol and drug use are consistently among the strongest predictors of delinquency in adolescent samples, but the direction of causality and the mediating mechanisms are contested. Research supports a bidirectional relationship: early delinquency predicts subsequent substance use initiation, while early substance use predicts subsequent delinquency escalation — with the relationship strengthening over development as shared causal factors (impulsivity, delinquent peer associations, family dysfunction) and mutual reinforcement mechanisms compound each other.
Research by Dawkins on the specific pathways through which adolescent substance use contributes to delinquency identified three primary mechanisms beyond the general psychopharmacological effects: the delinquent peer associations embedded in the social contexts of adolescent drug use, the criminal network connections that drug procurement requires, and the specific school disengagement that heavy substance use produces by disrupting the educational investment and school bonding that are primary protectors against delinquency. Research on school-based prevention programs — including Life Skills Training (LST) and the Strengthening Families Program — has found consistent evidence that programs effective in reducing adolescent substance use produce parallel reductions in delinquency, consistent with shared causal factor accounts and with the peer and school mechanism accounts.
Research on the specific vulnerability of adolescents to addiction — drawing on the developmental neuroscience establishing that adolescent brain circuitry is more reward-sensitive and less regulatory than adult circuitry — has established that adolescent initiation of substance use produces substantially elevated lifetime addiction risk relative to adult initiation. Research by Anthony and Petronis found that the probability of developing alcohol dependence was approximately two to four times higher for individuals who initiated drinking before age 15 than for those who initiated in adulthood — establishing prevention of early adolescent substance use initiation as a primary long-term crime prevention strategy through the addiction pathway.
Treatment as Crime Prevention
Medication-Assisted Treatment
Medication-assisted treatment (MAT) — the use of FDA-approved medications (methadone, buprenorphine/naloxone, naltrexone) alongside behavioral counseling for opioid and alcohol use disorders — represents the most evidence-supported addiction treatment approach available and has substantial evidence for crime reduction alongside its substance use outcomes. Research on methadone maintenance treatment has consistently found 50–70% reductions in criminal activity among participants relative to pre-treatment periods, effects that exceed those of any other criminal justice intervention for substance-using offenders. Research on buprenorphine treatment in criminal justice settings has found comparable reductions in both drug use and criminal behavior.
Despite this evidence, MAT is dramatically underutilized in criminal justice settings: research by Friedmann and colleagues found that fewer than 5% of substance-using offenders in the criminal justice system receive MAT during their period of supervision, and many correctional facilities explicitly prohibit methadone and buprenorphine despite their evidence base. The barrier is partly stigma (the perception that MAT replaces one addiction with another), partly cost, and partly the correctional culture’s preference for abstinence-based approaches that have weaker evidence for this population. Research demonstrating that expanding MAT access in criminal justice settings is both more effective and more cost-effective than abstinence-only alternatives has slowly begun to shift policy in states including Massachusetts, Rhode Island, and Vermont, which have implemented medication in jails and prisons with demonstrable improvements in both health and criminal justice outcomes.
Drug Courts and Therapeutic Jurisprudence
Drug courts — which divert drug-involved defendants from conventional prosecution into judicially supervised treatment programs combining accountability, treatment, and graduated sanctions — are among the most extensively evaluated and most consistently effective criminal justice interventions for substance-using offenders. Meta-analyses by Mitchell and colleagues synthesizing over 90 evaluations found significant reductions in recidivism (approximately 8–14 percentage points) for drug court participants compared to conventionally processed defendants, with the effects sustained across studies using varying methodological approaches and comparison groups.
Research on the specific program features associated with stronger drug court outcomes has found that programs following the 10 key components of drug courts developed by the National Association of Drug Court Professionals — including early identification and intake, non-adversarial collaboration, frequent drug testing, ongoing judicial interaction, and a continuum of treatment services — produce substantially better outcomes than those implementing these features incompletely. The National Drug Court Institute provides training and technical assistance to drug court programs implementing these evidence-based practices.
Harm Reduction and Crime
Harm reduction — the public health approach that aims to reduce the negative consequences of substance use without requiring abstinence — has accumulated a substantial evidence base for effectiveness in reducing both health harms and, in some cases, criminal behavior associated with substance use. Needle exchange programs (now called syringe services programs), which provide sterile injection equipment to people who inject drugs without requiring abstinence, have been documented to reduce HIV and hepatitis C transmission rates without increasing drug use or drug-related crime in the surrounding community — directly contradicting early objections that providing services to active drug users would increase community crime rates.
Research on overdose prevention centers — facilities that provide a safe, supervised space for drug use with immediate overdose response capability — has found substantial reductions in overdose deaths in the surrounding community without increases in drug use or drug market activity near the facilities. Research evaluating the Vancouver Insite supervised injection facility — the longest-operating such facility in North America — found consistent reductions in overdose deaths, no increases in drug-related crime or public disorder, and substantial reductions in needle sharing in the surrounding area. The evidence from Insite and similar European facilities has informed the opening of overdose prevention centers in New York City in 2021, the first officially sanctioned facilities in the United States.
Naloxone distribution programs — which provide the opioid overdose reversal medication to people who use opioids and to community members who may witness overdoses — have been documented to reduce opioid overdose mortality in communities where distribution is widespread. Research by Walley and colleagues on Massachusetts communities found that communities with high naloxone distribution rates had substantially lower opioid overdose death rates than communities with lower distribution, consistent with a direct causal effect of naloxone availability on mortality rather than selection of lower-risk communities into program participation.
Coercive Treatment, Autonomy, and Evidence
Research on coerced addiction treatment — treatment delivered under criminal justice mandate or threat of legal sanction — has found generally positive effects on substance use and criminal behavior outcomes compared to untreated control groups, but effects that are somewhat smaller than those produced by voluntary treatment and that reflect both the genuine therapeutic benefits of treatment and the behavioral compliance effects of supervision. Research by Farabee and colleagues synthesizing the coerced treatment literature found that legally coerced treatment produced recidivism reductions comparable to voluntary treatment for similar risk levels, with the mechanisms including both genuine therapeutic change and the specific deterrence of continued supervision that coerced treatment maintains.
Drug courts — reviewed above — represent the most structured form of coerced treatment in the United States, with the combination of judicial oversight, mandatory treatment, and graduated sanctions producing better outcomes than either purely criminal justice processing or purely voluntary treatment for the legally involved substance-using population they serve. Research distinguishing the specific contribution of the judicial relationship — the ongoing contact with the drug court judge — from the treatment component has found that both contribute independently to outcomes, establishing judicial oversight as a genuine therapeutic mechanism in addition to its deterrence function.
The ethical tension between the public health benefits of coerced treatment and the autonomy rights of individuals with addiction disorders has been extensively debated in both the legal and bioethical literatures. Research on the experiences of individuals in coerced treatment — finding mixed results on perceived voluntariness and therapeutic alliance, with some reporting genuine therapeutic engagement and others reporting pure compliance behavior — establishes that the ethics of coercion cannot be resolved solely by reference to outcome evidence but requires engagement with the specific rights and dignity interests of people with addiction that public health framings sometimes obscure.
Race, Drug Policy, and Criminal Justice Inequality
The relationship between substance use, crime, and race in the United States cannot be adequately addressed without confronting the racially disparate enforcement of drug laws that has been one of the primary drivers of mass incarceration and racial inequality in the criminal justice system. Research consistently documents that Black Americans are arrested for drug offenses at approximately three to four times the rate of white Americans despite comparable rates of drug use across racial groups — a disparity that reflects racially concentrated drug law enforcement in specific urban communities rather than differential behavior.
Research by Michelle Alexander and others on the racial politics of the war on drugs has documented how the specific enforcement choices of drug prohibition — concentrated in Black urban communities, applied with dramatically different intensity across racial groups engaging in similar behavior — have produced the criminal records, civic exclusions, and employment barriers that constitute a racially structured system of legal disadvantage whose consequences extend far beyond the criminal justice system. Research on the crime consequences of marijuana decriminalization and its racially disparate arrest reductions — finding that Black arrest rates fell more than white rates following decriminalization, narrowing the racial enforcement gap — provides specific evidence that drug policy reform can simultaneously advance racial equity and public safety.
Conclusion
Addiction, substance abuse, and crime are connected through the pharmacological, economic, and social-organizational mechanisms that the tripartite framework identifies — mechanisms whose specific contribution to criminal behavior varies by substance, by individual, and by social context in ways that defy simple causal narratives in either the “drugs cause crime” or “drugs don’t cause crime” directions. The evidence supports a nuanced account: specific substances do elevate specific crime risks through specific mechanisms, those mechanisms are genuinely causal rather than merely correlational in many cases, and treatment that addresses substance use as the health condition it is produces meaningful and cost-effective crime reduction. The most consequential policy question in the drug-crime nexus is not whether substance use causes crime — it does, through the mechanisms this article reviews — but whether criminalization of that substance use is the most effective available response to those mechanisms, or whether it is a historically and politically contingent policy choice that produces the incarceration costs and racial equity harms documented above without the public safety benefits that evidence-based treatment achieves at substantially lower cost.
The policy implications are equally specific: invest in the evidence-based treatments — medication-assisted treatment, drug courts, integrated dual diagnosis treatment — that reduce substance use and criminal behavior simultaneously; reform drug enforcement to address the racial disparities that undermine legal legitimacy while failing to produce public safety returns; and extend decriminalization to substances whose primary crime contribution operates through the market violence that prohibition produces rather than through pharmacological effects. A drug policy designed around evidence rather than politics would look substantially different from what American jurisdictions have built — and would produce substantially better public safety outcomes. The trajectory of American drug policy since the early 2000s — toward diversion, decriminalization, harm reduction, and medication-assisted treatment, in state after state responding to the opioid epidemic’s devastating body count — represents the belated recognition that criminalization has failed on its own terms. Whether that trajectory accelerates to produce the fundamental reorientation that the evidence supports, or stalls in the face of political resistance and cultural stigma, will determine whether addiction and crime remain as tightly bound as American drug policy has made them, or whether evidence-based treatment achieves the public safety, health, and equity outcomes that decades of research have established as achievable.
References
- Alexander, M. (2010). The new Jim Crow: Mass incarceration in the age of colorblindness. New Press.
- American Society of Addiction Medicine. (2019). Definition of addiction. https://www.asam.org/quality-care/definition-of-addiction
- Blumstein, A. (1995). Youth violence, guns, and the illicit-drug industry. Journal of Criminal Law and Criminology, 86(1), 10–36. https://doi.org/10.2307/1144012
- Chermack, S. T., & Blow, F. C. (2002). Violence among individuals in substance abuse treatment: The role of alcohol and cocaine consumption. Drug and Alcohol Dependence, 66(1), 29–37. https://doi.org/10.1016/S0376-8716(01)00180-6
- Cloward, R. A., & Ohlin, L. E. (1960). Delinquency and opportunity: A theory of delinquent gangs. Free Press.
- Farabee, D., Prendergast, M., & Anglin, M. D. (1998). The effectiveness of coerced treatment for drug-abusing offenders. Federal Probation, 62(1), 3–10.
- Friedmann, P. D., Hoskinson, R., Gordon, M., Schwartz, R., Kinlock, T., Knight, K., Flynn, P. M., Welsh, W. N., Stein, L. A. R., Sacks, S., O’Connell, D. J., Knudsen, H. K., Shafer, M. S., Hall, E., & Frisman, L. K. (2012). Medication-assisted treatment in criminal justice agencies affiliated with the Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): Availability, barriers, and intentions. Substance Abuse, 33(1), 9–18. https://doi.org/10.1080/08897077.2011.611460
- Goldstein, P. J. (1985). The drugs/violence nexus: A tripartite conceptual framework. Journal of Drug Issues, 15(4), 493–506. https://doi.org/10.1177/002204268501500406
- Kilmer, B., Nicosia, N., Heaton, P., & Midgette, G. (2013). Efficacy of frequent monitoring with swift, certain, and modest sanctions for violations: Insights from South Dakota’s 24/7 Sobriety Project. American Journal of Public Health, 103(1), e37–e43. https://doi.org/10.2105/AJPH.2012.300989
- Leonard, K. E., & Quigley, B. M. (1999). Drinking and marital aggression in newlyweds: An event-based analysis of drinking and the occurrence of husband marital aggression. Journal of Studies on Alcohol, 60(4), 537–545. https://doi.org/10.15288/jsa.1999.60.537
- Mitchell, O., Wilson, D. B., Eggers, A., & MacKenzie, D. L. (2012). Assessing the effectiveness of drug courts on recidivism: A meta-analytic review of traditional and non-traditional drug courts. Journal of Criminal Justice, 40(1), 60–71. https://doi.org/10.1016/j.jcrimjus.2011.11.009
- Morris, R. G., TenEyck, M., Barnes, J. C., & Kovandzic, T. V. (2014). The effect of medical marijuana laws on crime: Evidence from state panel data, 1990–2006. PLOS ONE, 9(3), e92816. https://doi.org/10.1371/journal.pone.0092816
- National Institute on Drug Abuse. (2020). Drugs, brains, and behavior: The science of addiction. https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction
- Reuter, P., MacCoun, R., & Murphy, P. (1990). Money from crime: A study of the economics of drug dealing in Washington, D.C. RAND Corporation.
- Rosenfeld, R., & Weisburd, D. (2016). Explaining recent crime trends. Journal of Quantitative Criminology, 32(3), 329–341. https://doi.org/10.1007/s10940-016-9309-z
- Substance Abuse and Mental Health Services Administration. (2023). Key substance use and mental health indicators in the United States: Results from the 2022 National Survey on Drug Use and Health. https://www.samhsa.gov/data/report/2022-nsduh-annual-national-report
- Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016). Neurobiologic advances from the brain disease model of addiction. New England Journal of Medicine, 374(4), 363–371. https://doi.org/10.1056/NEJMra1511480
- White, W. L. (1998). Slaying the dragon: The history of addiction treatment and recovery in America. Chestnut Health Systems.
- Wilson, J. Q., & Herrnstein, R. J. (1985). Crime and human nature. Simon & Schuster.
- Zinberg, N. E. (1984). Drug, set, and setting: The basis for controlled intoxicant use. Yale University Press.